MSK research highlights, December 29, 2023
New research from Memorial Sloan Kettering Cancer Center (MSK) developed CAR T cells that target two acute myeloid leukemia-specific antigens; shed new light on a genetic element called LINE-1, opening the door to new...
Korean Artificial Sun, KSTAR, installation of a tungsten divertor for long pulse operations
The Korean artificial sun, KSTAR, has completed divertor upgrades, allowing it to operate for extended periods sustaining high-temperature plasma over the 100 million degrees.
Credit: Korea Institute of Fusion Energy (KFE)
The Korean artificial sun, KSTAR,...
Insilico Medicine develops new AI-generated FGFR2/3 inhibitor for tissue-agnostic solid tumors
Insilico Medicine ("Insilico"), a generative artificial intelligence (AI)-driven clinical-stage drug discovery company, today announced the nomination of ISM8001, a novel molecule targeting FGFR2/3 for the treatment of tissue-agnostic solid tumors bringing the total number...
Degron Therapeutics announced as winner of AFCR’s 2023 BRACE Award Venture Competition
The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition. AFCR's BRACE (Bridging Research from Academia to Cancer...
Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture...
The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition.
Credit: Asian Fund for Cancer Research Limited
The Asian Fund...
Up-to-$2B Sanofi Collaboration Pays Off for Kymera
Through a pair of recent clinical milestones, Kymera Therapeutics continues to cash in on its up-to-$2 billion collaboration with Sanofi to develop first-in-class targeted protein degradation (TPD) therapies for patients with immune-inflammatory diseases.
Kymera this...
Scientists use organoid model to identify potential new pancreatic cancer treatment
A drug screening system that models cancers using lab-grown tissues called organoids has helped uncover a promising target for future pancreatic cancer treatments, according to a new study from researchers at Weill Cornell Medicine.
Credit:...
Electronic “soil” enhances crop growth
Barley seedlings grow on average 50% more when their root system is stimulated electrically through a new cultivation substrate. In a study published in the journal PNAS, researchers from Linköping University have developed an...
Pipeline Pruning: Exscientia Cuts Programs to Sharpen Precision Oncology Focus
Andrew Hopkins, DPhil, Exscientia’s founder and CEO
If two’s company and three’s a crowd, then 30-plus is more like 10 crowds—and like a crowded elevator with that many people inside, a drug pipeline top-heavy with...
Live Christmas trees affect indoor air chemistry, NIST researchers find
Every holiday season, Americans buy nearly 30 million live Christmas trees. Many families enjoy not only having a live tree inside their homes but also smelling the fresh fragrance it creates. That smell comes...
